May 09, 2017 20:09 pm UTC| Business
NEW YORK, May 09, 2017 -- At the end of the settlement date of April 28, 2017, short interest in2,322 Nasdaq Global MarketSM securities totaled7,409,700,882 shares compared with7,392,861,463 shares in2,331 Global Market...
Ascent Capital Group Announces Financial Results for the Three Months Ended March 31, 2017
May 09, 2017 20:09 pm UTC| Business
ENGLEWOOD, Colo., May 09, 2017 -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three months ended March 31, 2017. Ascent is a holding company that owns MONI, one of...
Ascent Capital Group Announces Financial Results for the Three Months Ended March 31, 2017
May 09, 2017 20:09 pm UTC| Business
ENGLEWOOD, Colo., May 09, 2017 -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three months ended March 31, 2017. Ascent is a holding company that owns MONI, one of...
Autobytel to Present at Upcoming 2017 Investor Conferences
May 09, 2017 20:09 pm UTC| Business
IRVINE, Calif., May 09, 2017 -- Autobytel Inc. (NASDAQ:ABTL), a pioneer and leading provider of digital automotive services connecting in-market car buyers with dealers and OEMs, will present at four financial...
Ascent Capital Group Announces Financial Results for the Three Months Ended March 31, 2017
May 09, 2017 20:09 pm UTC| Business
ENGLEWOOD, Colo., May 09, 2017 -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three months ended March 31, 2017. Ascent is a holding company that owns MONI, one of...
Autobytel to Present at Upcoming 2017 Investor Conferences
May 09, 2017 20:09 pm UTC| Business
IRVINE, Calif., May 09, 2017 -- Autobytel Inc. (NASDAQ:ABTL), a pioneer and leading provider of digital automotive services connecting in-market car buyers with dealers and OEMs, will present at four financial...
TESARO Announces First-Quarter 2017 Operating Results
May 09, 2017 20:09 pm UTC| Business
ZEJULA™ approved by U.S. FDA for the maintenance treatment of women with recurrent ovarian cancer, regardless of BRCA or biomarker status; commercial launch underwayZEJULA added to the NCCN Clinical Practice Guidelines in...